MedPath

Haloperidol

HALOPERIDOL TABLETS, USP Rx only

Approved
Approval ID

35573a97-e20d-4509-8178-8c08de3ab33f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2024

Manufacturers
FDA

REMEDYREPACK INC.

DUNS: 829572556

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Haloperidol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70518-3440
Application NumberANDA071173
Product Classification
M
Marketing Category
C73584
G
Generic Name
Haloperidol
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 11, 2024
FDA Product Classification

INGREDIENTS (5)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
D&C YELLOW NO. 10 ALUMINUM LAKEInactive
Code: CQ3XH3DET6
Classification: IACT
HALOPERIDOLActive
Quantity: 1 mg in 1 1
Code: J6292F8L3D
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol - FDA Drug Approval Details